We’re excited to make innovation in medicine the focus of this month’s newsletter and to introduce you to two Canadian trailblazers who are making profound changes in the treatment of diabetes and gynecologic cancers.
Our November Impact Story features Dr. Harald Stöver, Professor in the Faculty of Science at McMaster University and founder and CEO of Allarta Life Science. You’ll learn how Harald has moved his research on polymer hydrogels, bio-relevant macromolecules and the delivery of biologics from the laboratory to market to fundamentally change the way that patients with Type 1 Diabetes receive treatment.
You’ll also meet Dr. Laura Hopkins, a gynecological oncologist with the Saskatchewan Cancer Agency and Professor in the Division of Oncology and Provincial Lead for Gynecologic Oncology. A dedicated clinician, Laura’s devotion to providing excellent and timely care for patients through all stages of cancer treatment has led to the launch of the Saskatchewan Cancer Agency’s first investigator-initiated trial to explore patients’ preferences for precision medicine in ovarian cancer.
In keeping with the focus on medical technology innovations, this month’s Research Spotlight explores technologies that are providing advanced tools that, thanks to innovative research partnerships between clinicians, scientists, patients and industry, are vastly improving patient care and clinical outcomes.
This month’s newsletter also features an article about CANARIE, Canada’s National Research and Education Network, in recognition of its 30th anniversary. Along with its provincial and territorial partners, CANARIE operates NREN, Canada’s National Research and Education Network. This nationwide, ultra-high-speed network connects Canada’s researchers, educators, and innovators to each other and to global data, technology, and colleagues.
In late October, I was appointed as Vice-Chair for the CANARIE Board. I am extremely honoured to take on this role and have the opportunity to work closely with the Board Chair, Larry Rosia, President and CEO of Saskatchewan Polytechnic, Past Chair, Sylvie LaPerriere and the other Board members. As the CEO of a female-founded company, I’m proud to serve on the board of an organization committed to diversity as reflected in the appointment of Kathryn Anthonisen, CANARIE’s first female President and CEO, and, when women occupy just 23% of board seats in Canada, a board that is 60% female.
Thank you for connecting with us and the Profound Impact community.
Sherry Shannon-Vanstone